Quest PharmaTech Inc. announced earnings results for the third quarter ended October 31, 2020. For the third quarter, the company announced net income was CAD 3.782 million compared to net loss of CAD 1.603 million a year ago. Basic earnings per share from continuing operations was CAD 0.023 compared to basic loss per share from continuing operations of CAD 0.01 a year ago. Diluted earnings per share from continuing operations was CAD 0.022 compared to diluted loss per share from continuing operations of CAD 0.01 a year ago. For the nine months, net income was CAD 113.034 million compared to net loss of CAD 4.327 million a year ago. Basic earnings per share from continuing operations was CAD 0.674 compared to basic loss per share from continuing operations of CAD 0.026 a year ago. Diluted earnings per share from continuing operations was CAD 0.663 compared to diluted loss per share from continuing operations of CAD 0.026 a year ago.